🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 16 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/11/2013 6,98 7,25 6,80 7,10 +1,43% 6,45% 357.200
31/10/2013 6,94 7,02 6,26 7,00 +0,72% 10,95% 1.072.100
30/10/2013 7,66 7,76 6,73 6,95 -9,15% 13,50% 815.400
29/10/2013 7,70 7,85 7,50 7,65 -0,13% 4,55% 324.200
28/10/2013 7,92 7,92 7,51 7,66 -4,13% 5,18% 466.900
25/10/2013 8,06 8,06 7,77 7,99 -0,25% 3,60% 240.400
24/10/2013 8,04 8,04 7,73 8,01 +0,38% 3,86% 262.100
23/10/2013 7,94 8,10 7,61 7,98 -0,13% 6,15% 364.700
22/10/2013 8,88 8,88 7,53 7,99 -9,72% 15,20% 1.668.100
21/10/2013 8,11 8,88 8,10 8,85 +12,45% 9,62% 1.457.600
18/10/2013 8,18 8,25 7,55 7,87 -3,55% 8,56% 508.600
17/10/2013 8,17 8,30 7,91 8,16 +0,62% 4,77% 310.500
16/10/2013 8,12 8,30 8,08 8,11 +0,37% 2,71% 367.800
15/10/2013 8,20 8,33 7,82 8,08 -1,34% 6,21% 374.300
14/10/2013 8,00 8,48 7,73 8,19 +1,74% 9,36% 876.900
11/10/2013 8,00 8,07 7,55 8,05 +0,50% 6,50% 1.031.900
10/10/2013 7,37 8,27 7,00 8,01 +10,79% 17,23% 1.746.000
09/10/2013 6,82 7,35 6,00 7,23 +6,01% 19,79% 1.414.400
08/10/2013 6,15 7,53 6,06 6,82 +16,38% 23,90% 3.084.400
07/10/2013 5,97 6,09 5,85 5,86 -2,98% 4,02% 266.500
04/10/2013 6,05 6,08 5,89 6,04 +0,33% 3,06% 212.500
03/10/2013 6,04 6,15 5,88 6,02 -0,99% 4,47% 222.200
02/10/2013 6,05 6,27 6,00 6,08 +0,50% 4,46% 401.600
01/10/2013 5,69 6,13 5,65 6,05 +6,33% 8,44% 1.117.400
30/09/2013 6,00 6,07 5,45 5,69 -5,95% 10,33% 414.700
27/09/2013 5,85 6,20 5,75 6,05 +4,49% 7,69% 826.800
26/09/2013 5,61 5,84 5,35 5,79 +6,83% 8,73% 790.700
25/09/2013 5,21 5,70 5,11 5,42 +3,63% 11,32% 1.011.500
24/09/2013 4,85 5,55 4,79 5,23 +8,96% 15,67% 1.691.500
23/09/2013 4,73 4,81 4,51 4,80 +1,05% 6,34% 246.400